Stribild and Exercise tolerance decreased - a phase IV clinical study of FDA data

Summary:

Exercise tolerance decreased is reported as a side effect among people who take Stribild (cobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarate), especially for people who are male, 50-59 old, have been taking the drug for 2 - 5 years also take Atripla, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Exercise tolerance decreased when taking Stribild. It is created by eHealthMe based on reports of 16,366 people who have side effects when taking Stribild from the FDA, and is updated regularly.

What is Stribild?

Stribild has active ingredients of cobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarate. It is often used in hiv infection. eHealthMe is studying from 16,425 Stribild users. Check the latest studies of Stribild.

What is Exercise tolerance decreased?

Exercise tolerance decreased is found to be associated with 625 drugs and 725 conditions by eHealthMe. Check the latest studies of Exercise tolerance decreased.

On Jul, 28, 2026

16,366 people reported to have side effects when taking Stribild.
Among them, 23 people (0.14%) have Exercise tolerance decreased.

Could Stribild cause Exercise tolerance decreased?

Among these 23 people:

How long have people been on Stribild when they have Exercise tolerance decreased? *

What is the gender of people who have Exercise tolerance decreased when taking Stribild? *

female: 26.09 %
male: 73.91 %

What is the age of people who have Exercise tolerance decreased when taking Stribild? *

What are other drugs people take besides Stribild? *

What are other side effects people have besides Exercise tolerance decreased? *

Emotional Distress: 23 people, 100.00%
Pain: 23 people, 100.00%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 19 people, 82.61%
Stress And Anxiety: 19 people, 82.61%
Bone Density Decreased: 15 people, 65.22%
Depression: 14 people, 60.87%
Osteoporosis (bones weak and more likely to break): 11 people, 47.83%
Renal Impairment (severely reduced kidney function): 8 people, 34.78%
Mobility Decreased (ability to move is reduced): 6 people, 26.09%
Chronic Kidney Disease: 6 people, 26.09%

What are the existing conditions these people have? *

High Blood Pressure: 3 people, 13.04%
Pain: 3 people, 13.04%
Bacterial Infection: 3 people, 13.04%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 13.04%
Skin Disorder (skin disease): 2 people, 8.70%
Androgen Deficiency: 2 people, 8.70%
Blood Potassium Decreased: 2 people, 8.70%
Depression: 2 people, 8.70%
Erection Problems: 2 people, 8.70%
Sleep Apnea Syndrome: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Stribild and have Exercise tolerance decreased?

- Check whether Exercise tolerance decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Stribild:

Stribild (16,425 reports)

Exercise tolerance decreased treatments and more:

Exercise tolerance decreased (6,725 reports)

How severe was Exercise tolerance decreased and when was it recovered:

Exercise tolerance decreased in Stribild

Expand to all the drugs that have ingredients of cobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarate:

Exercise tolerance decreased and drugs with ingredients of cobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Stribild:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Exercise tolerance decreased:

Exercise tolerance decreased (625 drugs)

Browse all the conditions that are associated with Exercise tolerance decreased:

Exercise tolerance decreased (725 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarate (the active ingredients of Stribild) and Stribild (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.